Question 1

What specific dose of MK3207 was most effective in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the MK3207 for Treatment of Acute Migraines (3207-005) clinical trial (NCT00712725). Contact the study team or your healthcare provider for specific answers.

Question 2

How does MK3207 compare to other migraine treatments I might be considering?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the MK3207 for Treatment of Acute Migraines (3207-005) clinical trial (NCT00712725). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I be aware of with MK3207?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the MK3207 for Treatment of Acute Migraines (3207-005) clinical trial (NCT00712725). Contact the study team or your healthcare provider for specific answers.

Question 4

How will I know if MK3207 is working for me during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the MK3207 for Treatment of Acute Migraines (3207-005) clinical trial (NCT00712725). Contact the study team or your healthcare provider for specific answers.

Question 5

What is the process for participating in this trial, including visits and monitoring?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the MK3207 for Treatment of Acute Migraines (3207-005) clinical trial (NCT00712725). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs or insurance considerations I should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the MK3207 for Treatment of Acute Migraines (3207-005) clinical trial (NCT00712725). Contact the study team or your healthcare provider for specific answers.

What this study is about